Summer is the best time for studying parasites. It is warm and damp near the beach and they grow well and fast. Recently, my father died and I was staying at his house on Cape Cod which is now being cleaned up and renovated. I reported previously that he died after falling from a brain hemorragh. The brain scan showed tiny points of bleeding all over the brain which really puzzled the clinicians. I had already diagnosed this parasite infection so it was no surprise to me. Unfortunately, my father was very sceptical of complementary medicine and would not be treated for it.

Following a 4th of July stay at his home, I detected a nasty parasite with five stages which manifested as itchy feet. Socks got contaminated and washing them would not remove the parasite. Only sonicating, zapping for exact frequencies, or bleach would eliminate them.

Frequencies for the primary strain of this parasite were 464054 348094 255154 135844 54323 with a secondary strain at 464224 380852 253544 173116 42245.

All frequencies must be eliminated simultaneously or the infection will persist. In most people this will be a lifelong infection. The microscopic image of Cryptosporidium parvum above is from the EPA web site. Using the Cameron Aurameter as a testing device, the frequency of the oocysts appears to be 255154, the nuclei in the oocysts 464054, and the lower two frequencies appear to apply to other contents in the photo. The multistage nature of the life cycle of this parasite can be viewed at the University of Waterloo web site.

The interesting aspect of this particular strain of the parasite is that it goes to valves in veins. My father had to have a heart valve replacement in the 1990’s. It was also associated with a second parasite released when killing the first with frequencies 415443 364415 256424 113542 86753. This parasite had the characteristic of going to the ears and disturbing balance. My father had gradually lost a lot of his hearing and was subject to more and more frequent falls up until he died.

These infections are familial and you have to eliminate them in all family members including animals. Most individuals will remain asymptomatic until their immune system becomes compromised. If itchy feet are treated topically the organisms seek hiding places internally in the body, particularly behind the blood brain barrier. And of course, if you mention you think you might have parasites in your brain to your physician, you run the risk of being referred to a psychiatrist.

I am finding that anyone exposed to the coronavirus associated with SARS needs to be checked about once a month for recurrent infections. On testing a bad case of diarrhea in a person previously exposed to the coronavirus some months ago, to my surprise, the frequency was 33557HZ. This case did respond to oscillicoccinum 200C.

As previously reported, on 28 May 2003, I picked up what appears to be a new SARS coronavirus strain with frequency 33557HZ. The previous strain which was persistent across a number of people was 33566HZ. The current protocol which has been working well has been modified. The new F100 program is:

label start

dwell 12

duty 42

converge 6 1

pulse 63.5 74.7

33557 # SARS coronavirus new strain

33566 # SARS coronavirus

255616 # SARS metapneumovirus

162 563 5613 5235 1556 2286 5763 8015 #SARS fragments and harmonics

9563 6157 5513 3735 1559 #SARS parasite

goto start

The original strain 33566HZ responds to the homeopathic remedy Oscillicoccinum 200C in the early stages. The new strain does not respond to Oscillicoccinum but does respond to Delisos Influenzinum ’01 9C.

For units which can only transmit up to 10000HZ, divide by a factor of 2 to get an octave lower than 10000HZ.

This program loops through the frequencies and if run for 10-15 minutes will cause symptoms to begin to disappear in individuals infected with these strains.

Effects of a Dietary Portfolio of Cholesterol-Lowering Foods vs Lovastatin on Serum Lipids and C-Reactive Protein

David J. A. Jenkins, MD; Cyril W. C. Kendall, PhD; Augustine Marchie, BSc; Dorothea A. Faulkner, PhD; Julia M. W. Wong, RD; Russell de Souza, RD; Azadeh Emam, BSc; Tina L. Parker, RD; Edward Vidgen, BSc; Karen G. Lapsley, DSc; Elke A. Trautwein, PhD; Robert G. Josse, MB, BS; Lawrence A. Leiter, MD; Philip W. Connelly, PhD

JAMA. 2003;290:502-510.

Context: To enhance the effectiveness of diet in lowering cholesterol, recommendations of the Adult Treatment Panel III of the National Cholesterol Education Program emphasize diets low in saturated fat together with plant sterols and viscous fibers, and the American Heart Association supports the use of soy protein and nuts.

Objective: To determine whether a diet containing all of these recommended food components leads to cholesterol reduction comparable with that of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins).

Design: Randomized controlled trial conducted between October and December 2002.

Setting and Participants: Forty-six healthy, hyperlipidemic adults (25 men and 21 postmenopausal women) with a mean (SE) age of 59 (1) years and body mass index of 27.6 (0.5), recruited from a Canadian hospital-affiliated nutrition research center and the community.

Interventions: Participants were randomly assigned to undergo 1 of 3 interventions on an outpatient basis for 1 month: a diet very low in saturated fat, based on milled whole-wheat cereals and low-fat dairy foods (n = 16; control); the same diet plus lovastatin, 20 mg/d (n = 14); or a diet high in plant sterols (1.0 g/1000 kcal), soy protein (21.4 g/1000 kcal), viscous fibers (9.8 g/1000 kcal), and almonds (14 g/1000 kcal) (n = 16; dietary portfolio).

Main Outcome Measures: Lipid and C-reactive protein levels, obtained from fasting blood samples; blood pressure; and body weight; measured at weeks 0, 2, and 4 and compared among the 3 treatment groups.

Results: The control, statin, and dietary portfolio groups had mean (SE) decreases in low-density lipoprotein cholesterol of 8.0% (2.1%) (P = .002), 30.9% (3.6%) (P<.001), and 28.6% (3.2%) (P<.001), respectively. Respective reductions in C-reactive protein were 10.0% (8.6%) (P = .27), 33.3% (8.3%) (P = .002), and 28.2% (10.8%) (P = .02). The significant reductions in the statin and dietary portfolio groups were all significantly different from changes in the control group. There were no significant differences in efficacy between the statin and dietary portfolio treatments. Conclusion: In this study, diversifying cholesterol-lowering components in the same dietary portfolio increased the effectiveness of diet as a treatment of hypercholesterolemia.

Alternative practitioners have long argued that vaccines are a major assault on the bodies immune system and homeopaths regularly treat adults for after effects of vaccines received in childhood. The problem is exaggerated by the U.S. practice of giving multiple vaccines to infants at younger and younger ages. The Japanese take a much more careful approach to vaccination using safer vaccines administered at older ages, a practice that the U.S. would do well to follow.

Any hard look at the evidence on vaccines over the last hundred years raises many unanswered questions about effectiveness and side effects. Those of us who were “saved” from polio in the early 1960s have SV40 virus infections and some of us have cancer to go along with it. Some European countries did not implement a polio vaccination program at the time and their rates of polio dropped as fast as the U.S.. This is only one puzzling data point and their are many others.

United Press International looks at the darker side of vaccination programs. Who promotes them, and who profits from them?

UPI Investigates: The vaccine conflict

By Mark Benjamin

Investigations Editor

Published 7/20/2003 8:45 AM

WASHINGTON, July 20 (UPI) — The screaming started four hours after 8-month-old Chaise Irons received a vaccination against rotavirus, recommended in June 1998 by the Centers for Disease Control and Prevention for every infant to prevent serious diarrhea.

Within a day he was vomiting and eliminating blood. Doctors performed emergency surgery, saving him by repairing his intestines, which were folding in on one another. A doctor later figured out the vaccine caused Chaise’s problem.

In October 1999, after 15 reports of such incidents, the CDC withdrew its recommendation for the vaccination — not because of the problem, the agency claims, but because bad publicity might give vaccines in general a bad name.

But a four-month investigation by United Press International found a pattern of serious problems linked to vaccines recommended by the CDC — and a web of close ties between the agency and the companies that make vaccines.

Sunday, Jul 20, 2003, front page

… Bernadine Healy, who became the first woman to lead the National Institutes of Health that year [1991], was convinced that the rush to put hormones into the hands of every woman over 50 was a reckless pursuit based on insufficient science.

“We were on a fast train to putting estrogen and progestin in every woman’s drinking water,” she recalled…

The stellar rise and spectacular fall of hormone replacement therapy ranks among the biggest medical mistakes in history, fueled by a combination of weak science, relentless hype, the herd mentality of doctors, and women’s dawning redefinition of menopause from an inevitable “change of life” to a manageable condition.

Now, a year after the first of a series of bombshell studies demolished widely held beliefs about hormone replacement, physicians and patients alike continue to reel from the reality that the pills cause some of the very problems they aim to prevent, including heart disease and impaired mental states…

The impact of antibiotic resistant bacteria continues to increase. The full text of a Congressional report on this topic is available online. Antibiotics should be used for emergencies and not routine treatment. In the future, those who want to survive will use electromagnetic devices to control infection.

U.S. Congress, Office of Technology Assessment, Impacts of Antibiotic-Resistant Bacteria, OTA-H-629 (Washington, DC: U.S.

Government Printing Office, September 1995).

“Penicillin, the first antibiotic, and the more than 100 other antibiotics now available to physicians are the primary weapons in mankind’s battle against bacterial diseases. They revolutionized medicine, providing cures for formerly life-threatening diseases and preventing many previously inevitable deaths from

infected wounds. They still do, but within a short time of each antibiotic’s introduction into medicine, some bacteria became resistant to it, and the antibiotic lost its effectiveness against some diseases. Currently, few bacteria are resistant to all antibiotics, but many more are resistant to all but one or all but a few antibiotics, and the expectation is that resistant bacteria will continue to emerge and spread. The fear is that many bacteria will become resistant to all antibiotics, plunging humanity back into the conditions that existed in the pre-antibiotic age.

“OTA’s report discusses what is known about the emergence and spread of antibiotic-resistant bacteria and describes research and development aimed at controlling those organisms. It concludes that efforts are necessary both to preserve the effectiveness of currently available antibiotics and to develop new antibiotics. It discusses issues that arise in these activities, and it presents options for taking action.

“This report was requested by the House Committee on Energy and Commerce in the 103d Congress (now the House Committee on Commerce).

The Senate Committee on Labor and Human Resources in the same Congress endorsed the request for the study.”

Long-Term Trends in the Use of Complementary and Alternative Medical Therapies in the United States

Ronald C. Kessler, PhD; Roger B. Davis, ScD; David F. Foster, MD; Maria I. Van Rompay, BA; Ellen E. Walters, MS; Sonja A. Wilkey, BA; Ted J. Kaptchuk, OMD; and David M. Eisenberg, MD

Ann Intern Med. 2001;135:262-268.

Background: Although recent research has shown that many people in the United States use complementary and alternative medical (CAM) therapies, little is known about time trends in use.

Objective: To present data on time trends in CAM therapy use in the United States over the past half-century.

Design: Nationally representative telephone survey of 2055 respondents that obtained information on current use, lifetime use, and age at first use for 20 CAM therapies.

Setting: The 48 contiguous U.S. states.

Participants: Household residents 18 years of age and older.

Measurement: Retrospective self-reports of age at first use for each of 20 CAM therapies.

Results: Previously reported analyses of these data showed that more than one third of the U.S. population was currently using CAM therapy in the year of the interview (1997). Subsequent analyses of lifetime use and age at onset showed that 67.6% of respondents had used at least one CAM therapy in their lifetime. Lifetime use steadily increased with age across three age cohorts: Approximately 3 of every 10 respondents in the pre–baby boom cohort, 5 of 10 in the baby boom cohort, and 7 of 10 in the post–baby boom cohort reported using some type of CAM therapy by age 33 years. Of respondents who ever used a CAM therapy, nearly half continued to use many years later. A wide range of individual CAM therapies increased in use over time, and the growth was similar across all major sociodemographic sectors of the study sample.

Conclusions: Use of CAM therapies by a large proportion of the study sample is the result of a secular trend that began at least a half century ago. This trend suggests a continuing demand for CAM therapies that will affect health care delivery for the foreseeable future.

This article supports one aspect of a basic principle that I am trying to articulate on this web site. The majority of chronic diseases are caused by pathogens. They can be eliminated by electronic devices. Recurrence can be prevented by the right exercise, nutrition, and supplement program.

Mental ailments in children being linked to strep

By Carey Goldberg, Globe Staff, 6/28/2003

ENNEBUNKPORT, Maine — Sammy Jelin, math whiz and natural comedian, sailed through fifth grade, a school enthusiast eager for the bus each morning. By the start of sixth grade last fall, he could barely make it to school at all: In just weeks, his world had turned into a minefield of germ phobias, invisible walls, and constant tics — hallmarks of obsessive compulsive disorder and Tourette’s syndrome.

By this May, Sammy’s mother, Beth Jelin, was nearing her wits’ end. Then an acquaintance mentioned that her son had contracted similar mental ailments through a streptococcus infection. The idea sounded wild, especially because Sammy had never had strep throat. But a prompt blood test did turn up unusually high levels of strep, and Sammy went on antibiotics.

Once again, I salute the British Medical Journal for providing all articles online. This is a tremendous service to people worldwide.

The article below articulates a major problem very well. Some diseases are now “fabricated” by the medical industry and drugs are created and prescribed that you must be on for a lifetime to treat this fabricated disease. Some of these drugs cause side effects which can not only be deadly, but can make it impossible to get off the drug. Thus the holy grail is achieved. A self sustaining disease state is created that requires buying the drug for the rest of your life.

I find it difficult to talk about these issue with people. My wife, who is the daughter of several generations of devoted physicians, accuses me of paranoia (at best) or libel (at worst) for even mentioning it. Yet the leading medical journals all have articles that should be read by every personal who uses the healthcare system. Beware of your local drug dealer, even if they appear to be reputable professionals!

As a businessman, I understand “disease mongering” is just “business as usual.” In the computer industry, where I work, things are even more ferocious in the battle for market share. However, the fact that in the last two weeks the CEO’s of major health care companies underwent some of the same fate as the leaders of Enron and Worldcom should cause the average person to ask deeper questions than they might have asked in the past. Cooking the books in healthcare can mean cooking the patients as well.

Selling sickness: the pharmaceutical industry and disease mongering

Ray Moynihan, Iona Heath, David Henry

British Medical Journal 334:13:886-891, 13 Apr 2002

A lot of money can be made from healthy people who believe they are sick. Pharmaceutical companies sponsor diseases and promote them to prescribers and consumers. Ray Moynihan, Iona Heath, and David Henry give examples of “disease mongering” and suggest how to prevent the growth of this practice. There’s a lot of money to be made from telling healthy people they’re sick. Some forms of medicalising ordinary life may now be better described as disease mongering: widening the boundaries of treatable illness in order to expand markets for those who sell and deliver treatments. Pharmaceutical companies are actively involved in sponsoring the definition of diseases and promoting them to both prescribers and consumers. The social construction of illness is being replaced by the corporate construction of disease.

Whereas some aspects of medicalisation are the subject of ongoing debate, the mechanics of corporate backed disease mongering, and its impact on public consciousness, medical practice, human health, and national budgets, have attracted limited critical scrutiny. Within many disease categories informal alliances have emerged, comprising drug company staff, doctors, and consumer groups. Ostensibly engaged in raising public awareness about underdiagnosed and undertreated problems, these alliances tend to promote a view of their particular condition as widespread, serious, and treatable. Because these “disease awareness” campaigns are commonly linked to companies’ marketing strategies, they operate to expand markets for new pharmaceutical products. Alternative approaches—emphasising the self limiting or relatively benign natural history of a problem, or the importance of personal coping strategies—are played down or ignored. As the late medical writer Lynn Payer observed, disease mongers “gnaw away at our self­confidence.”

.

Sars patients ‘suffer brain damage’ from steroid cocktail

By Adam Luck in Hong Kong

(Filed: 01/06/2003)

Psychiatrists believe that up to 50 per cent of surviving Sars patients may have early signs of possibly irreversible brain and nerve damage after steroids were used experimentally to combat the potentially fatal virus.

Recovering Sars patients in Hong Kong have suffered from hallucinations, manic behaviour, rapid mood swings and memory loss after being treated with large doses of steroids.

Many are doctors and nurses who have found their concentration and short-term memory impaired since returning to work. Sars specialists say that it is too early to tell whether the problems are permanent.

________________________________________________________________________________________________

I checked two asymptomatic individuals who had exposure to SARS coronavirus. They both had residual virus in the brain and spinal cord confirming that the virus attacks the nervous system. Plate zapping for specific organ systems using SARS frequencies posted previously will clear it out and relieve lingering symptomology.